SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-036552
Filing Date
2011-06-14
Accepted
2011-06-14 16:46:50
Documents
1
Period of Report
2011-06-10

Document Format Files

Seq Description Document Type Size
1 VIVEASH JUNE GRANT rrd315185.html 4  
1 VIVEASH JUNE GRANT rrd315185.xml 4 4282
  Complete submission text file 0001181431-11-036552.txt   5663
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 3344 N. TORREY PINES CT., SUITE 200 LA JOLLA CA 92037
Business Address
Viveash Dawn (Reporting) CIK: 0001475720 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 11911031